ロード中...
Development and Bioanalytical Validation of a Liquid Chromatographic-Tandem Mass Spectrometric (LC-MS/MS) Method for the Quantification of the CCR5 Antagonist Maraviroc in Human Plasma
BACKGROUND: Maraviroc is a CCR5 antagonist that has been utilized as a viral entry inhibitor in the management of HIV-1. Current clinical trials are pursuing maraviroc drug efficacy in both oral and topical formulations. Therefore, in order to fully understand drug pharmacokinetics, a sensitive meth...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4029414/ https://ncbi.nlm.nih.gov/pubmed/24561264 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cca.2014.02.008 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|